Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
BUD compared with GSK: revenue, margins and what each company keeps, and the suppliers and customers both name
BUD
Anheuser-Busch InBev SA
Change
Mkt cap
Revenue
Revenue
GSK
GSK plc
Change
Mkt cap
Revenue
Revenue
vs
Compare
BUD
Anheuser-Busch InBev SA
vs
GSK
GSK plc
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Earnings history
Desk
News
Calendar
Saved
Search
Earnings history
last 4 reports each · paired by recency
Method
›
BUD
1 of 4 reports
0 of 1
at or beyond implied
Report
implied
realized
× implied
Oct 29 '26
±5.2%
▼
−1.80%
×0.35
GSK
No earnings history for GSK.
= implied
BUD realized, solid
GSK realized, hatched
One scale, both sides: full bar = 6%
× = |realized| ÷ implied
Source: market data
BUD
Anheuser-Busch InBev SA
Change
80.36
▲
+1.06%
· post 80.36
Mkt cap
$144.5B
GSK
GSK plc
Change
49.51
▲
+1.71%
· post 49.51
Closed
Oct 30 '26
Mkt cap
$106.8B
vs
Compare
Closed
Oct 30 '26
BUD
Anheuser-Busch InBev SA
vs
GSK
GSK plc
80.36
▲
+1.06%
post 80.36
Price
49.51
▲
+1.71%
post 49.51
$144.5B
Mkt cap
$106.8B
Change
Change
BUD
80.36
▲
+1.06%
vs
GSK
49.51
▲
+1.71%
Closed
Oct 30 '26